Physician profile

Brian Kim

Clinical Cardiac Electrophysiology · Kearney, NE

NPI 1609849876

$455,178.61

in general payments reported to CMS, 2019-2025

33 companies · $6,776 in 2025

The $6,776 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$126,767.28
Travel and Lodging$24,136.89
Food and Beverage$13,443.14
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$2,100.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Acutus Medical, INC. $259,040.20 2019-2023 Acqguide, Device
Abbott Laboratories $92,535.27 2019-2025 Aveir, Gallant, Accent
Biosense Webster, INC. $26,285.49 2019-2025 Carto 3, Qdot Micro, Octaray Mapping Catheter
Medtronic, INC. $25,627.99 2021-2025 Micra, Azure Xt Dr Mri Surescan, Linq II
Medtronic Vascular, INC. $25,293.90 2019-2020
Biotronik INC. $19,313.99 2019-2025 Biomonitor, Acticor 7 Vr-T Dx, Rivacor 7 Dr-T
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,731.43 2019-2024 Lifevest
Medical Device Business Services, INC. $1,160.18 2022
Atricure, INC. $853.13 2019-2025 Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System
Novartis Pharmaceuticals Corporation $611.78 2020-2024
Sanofi-Aventis U.S. LLC $491.13 2019-2023
Boston Scientific Corporation $474.75 2019-2024 Watchman Flx, Bodyguardian
Janssen Pharmaceuticals, INC $311.48 2019-2022
Impulse Dynamics (USA) INC. $286.03 2023-2025 Optimizer, Optimizer
E.R. Squibb & Sons, L.L.C. $245.99 2019-2025 Zeposia, Camzyos
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $185.56 2019-2025 Repatha, Repatha
Pfizer INC. $118.81 2019-2025
W. L. Gore & Associates, INC. $100.83 2019
Heartflow, INC. $73.31 2023-2024 Ffrct
Kestra Medical Technology Services, INC. $49.81 2022-2023 Assure Wcd
Cvrx, INC. $48.00 2024 Barostim Neo System
Cardiovascular Systems INC. $42.28 2019
Bardy Diagnostics, INC. $41.02 2019-2021
Astellas Pharma US INC $35.43 2021
Baxter Healthcare $32.97 2025 Hillrom - Cardiac Ambulatory Monitor
Cardiofocus, INC. $32.18 2022
Cardiva Medical, INC. $27.84 2023 Cardiva Vascade Mvp Vvcs 6-12f
Irhythm Technologies, INC. $27.41 2024 Zio Monitor, Zio Xt Patch
Biotissue Holdings INC. $25.00 2024
Biotronik Nro, INC. $22.55 2025 Prospera
Boehringer Ingelheim Pharmaceuticals, INC. $22.03 2019
Convatec INC. $19.41 2019
Gilead Sciences, INC. $11.43 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian Kim

$455,178.61

in general payments reported 2019-2025

Years
2019-2025
Top company
Acutus Medical, INC.
Context
The $6,776 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/163133/brian-kim

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.